Compare YDES & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YDES | ADTN |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Telecommunications Equipment |
| Sector | | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.8M | 559.8M |
| IPO Year | 2024 | 1996 |
| Metric | YDES | ADTN |
|---|---|---|
| Price | $5.85 | $6.71 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $14.67 |
| AVG Volume (30 Days) | 380.9K | ★ 1.4M |
| Earning Date | 08-31-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.83 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,083,807,000.00 |
| Revenue This Year | N/A | $5.74 |
| Revenue Next Year | N/A | $7.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.46 |
| 52 Week Low | $1.70 | $6.29 |
| 52 Week High | $18.57 | $19.98 |
| Indicator | YDES | ADTN |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 42.82 |
| Support Level | $4.97 | N/A |
| Resistance Level | $8.89 | $7.34 |
| Average True Range (ATR) | 1.01 | 0.31 |
| MACD | -0.18 | -0.03 |
| Stochastic Oscillator | 20.43 | 27.10 |
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.